RNAZ
TransCodeยทNASDAQ
--
--(--)
--
--(--)
RNAZ Profile
Transcode Therapeutics, Inc.
An oncology based biotech company that develops RNA therapeutics for the treatment of tumor
Biological Technology
01/11/2016
07/09/2021
NASDAQ Stock Exchange
7
12-31
Common stock
6 Liberty Square, #2382, Boston, MA 02109
--
TransCode Therapeutics, Inc., was incorporated under the laws of the State of Delaware on January 11, 2016. The company is an RNA oncology company founded on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapies. RNA-based therapies are highly selective for their targets and have the potential to provide a range of targets in the human genome that were previously untreatable with drugs.
